Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy

The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT). Stage II RAP secondary to age-related macular degeneration was docum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Graefe's archive for clinical and experimental ophthalmology 2006-11, Vol.244 (11), p.1528-1533
Hauptverfasser: Bottoni, Ferdinando, Romano, Mary, Massacesi, Amedeo, Bergamini, Fulvio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1533
container_issue 11
container_start_page 1528
container_title Graefe's archive for clinical and experimental ophthalmology
container_volume 244
creator Bottoni, Ferdinando
Romano, Mary
Massacesi, Amedeo
Bergamini, Fulvio
description The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT). Stage II RAP secondary to age-related macular degeneration was documented by dynamic digital fluorescein and indocyanine green angiography in 3 consecutive patients (3 eyes). All eyes were treated with intravitreal injection of TA (4 mg, 0.1 ml) followed by PDT 5-10 days later. Indocyanine green angiography (ICGA) revealed a complete remodeling of the vascular structure of the three RAPs after treatment. The feeding retinal artery, which shunted a major part of the blood flow from the original arteriole toward the intraretinal neovascular complex before treatment, regained a normal appearance after treatment. With RAP closure, the blood flow was again directed through the original retinal arteriole, and the connection to the RAP was no longer visible. Stage II RAPs are difficult lesions to treat. A real remodeling of the vascular lesion is achieved with the combined use of intravitreal TA and PDT. This finding corroborates the need for randomized clinical trials currently under way to evaluate this combination treatment in wet, age-related macular degeneration.
doi_str_mv 10.1007/s00417-006-0311-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68126804</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68126804</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-71accc0894256f650d4c221ac4f4588bf0edb9e6b8a25f184cc7c56f056b2e863</originalsourceid><addsrcrecordid>eNpdkc9q3DAQh0VpababPkAvRfTQm5uRbMv2sYT0DwQKoYHcxFgeZxVkaSvJKfsefeBq2YVCTxKj7zdi5mPsnYBPAqC7SgCN6CoAVUEtRDW8YBvR1G3VgXx4yTbQSVH1tXy4YG9SeoKC1614zS6EUjAM0GzYnztawkTO-kceZp53xJ8xmdVh5GaH3pNL3HoeKVuPjqN_tGHBHNbE9zE4O1PEbINPPEfCTBP_bfOuRHLEZ3usufJicTHWBxc8cTSUg7dTufmJ73chh-ngcbHm-H3E_eGSvZrRJXp7Prfs_svNz-tv1e2Pr9-vP99WppYqV51AYwz0QyNbNasWpsZIWYrN3LR9P85A0ziQGnuU7Sz6xpjOFBJaNUrqVb1lH099yyS_VkpZLzYZcg49lQG16oVUfVnaln34D3wKayz7SFrW0BVEigKJE2RiSCnSrPfRLhgPWoA--tInX7r40kdfeiiZ9-fG67jQ9C9xFlT_BQoYlRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230780421</pqid></control><display><type>article</type><title>Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Bottoni, Ferdinando ; Romano, Mary ; Massacesi, Amedeo ; Bergamini, Fulvio</creator><creatorcontrib>Bottoni, Ferdinando ; Romano, Mary ; Massacesi, Amedeo ; Bergamini, Fulvio</creatorcontrib><description>The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT). Stage II RAP secondary to age-related macular degeneration was documented by dynamic digital fluorescein and indocyanine green angiography in 3 consecutive patients (3 eyes). All eyes were treated with intravitreal injection of TA (4 mg, 0.1 ml) followed by PDT 5-10 days later. Indocyanine green angiography (ICGA) revealed a complete remodeling of the vascular structure of the three RAPs after treatment. The feeding retinal artery, which shunted a major part of the blood flow from the original arteriole toward the intraretinal neovascular complex before treatment, regained a normal appearance after treatment. With RAP closure, the blood flow was again directed through the original retinal arteriole, and the connection to the RAP was no longer visible. Stage II RAPs are difficult lesions to treat. A real remodeling of the vascular lesion is achieved with the combined use of intravitreal TA and PDT. This finding corroborates the need for randomized clinical trials currently under way to evaluate this combination treatment in wet, age-related macular degeneration.</description><identifier>ISSN: 0721-832X</identifier><identifier>EISSN: 1435-702X</identifier><identifier>DOI: 10.1007/s00417-006-0311-9</identifier><identifier>PMID: 16609904</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Aged ; Aged, 80 and over ; Coloring Agents ; Drug Therapy, Combination ; Female ; Fluorescein Angiography ; Glucocorticoids - therapeutic use ; Humans ; Indocyanine Green ; Injections ; Macular Degeneration - complications ; Male ; Photochemotherapy ; Regional Blood Flow - physiology ; Retinal Neovascularization - drug therapy ; Retinal Neovascularization - etiology ; Retinal Neovascularization - physiopathology ; Retinal Vessels - physiology ; Triamcinolone Acetonide - therapeutic use ; Vitreous Body</subject><ispartof>Graefe's archive for clinical and experimental ophthalmology, 2006-11, Vol.244 (11), p.1528-1533</ispartof><rights>Springer-Verlag 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c326t-71accc0894256f650d4c221ac4f4588bf0edb9e6b8a25f184cc7c56f056b2e863</citedby><cites>FETCH-LOGICAL-c326t-71accc0894256f650d4c221ac4f4588bf0edb9e6b8a25f184cc7c56f056b2e863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16609904$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bottoni, Ferdinando</creatorcontrib><creatorcontrib>Romano, Mary</creatorcontrib><creatorcontrib>Massacesi, Amedeo</creatorcontrib><creatorcontrib>Bergamini, Fulvio</creatorcontrib><title>Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy</title><title>Graefe's archive for clinical and experimental ophthalmology</title><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><description>The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT). Stage II RAP secondary to age-related macular degeneration was documented by dynamic digital fluorescein and indocyanine green angiography in 3 consecutive patients (3 eyes). All eyes were treated with intravitreal injection of TA (4 mg, 0.1 ml) followed by PDT 5-10 days later. Indocyanine green angiography (ICGA) revealed a complete remodeling of the vascular structure of the three RAPs after treatment. The feeding retinal artery, which shunted a major part of the blood flow from the original arteriole toward the intraretinal neovascular complex before treatment, regained a normal appearance after treatment. With RAP closure, the blood flow was again directed through the original retinal arteriole, and the connection to the RAP was no longer visible. Stage II RAPs are difficult lesions to treat. A real remodeling of the vascular lesion is achieved with the combined use of intravitreal TA and PDT. This finding corroborates the need for randomized clinical trials currently under way to evaluate this combination treatment in wet, age-related macular degeneration.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Coloring Agents</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Fluorescein Angiography</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Indocyanine Green</subject><subject>Injections</subject><subject>Macular Degeneration - complications</subject><subject>Male</subject><subject>Photochemotherapy</subject><subject>Regional Blood Flow - physiology</subject><subject>Retinal Neovascularization - drug therapy</subject><subject>Retinal Neovascularization - etiology</subject><subject>Retinal Neovascularization - physiopathology</subject><subject>Retinal Vessels - physiology</subject><subject>Triamcinolone Acetonide - therapeutic use</subject><subject>Vitreous Body</subject><issn>0721-832X</issn><issn>1435-702X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkc9q3DAQh0VpababPkAvRfTQm5uRbMv2sYT0DwQKoYHcxFgeZxVkaSvJKfsefeBq2YVCTxKj7zdi5mPsnYBPAqC7SgCN6CoAVUEtRDW8YBvR1G3VgXx4yTbQSVH1tXy4YG9SeoKC1614zS6EUjAM0GzYnztawkTO-kceZp53xJ8xmdVh5GaH3pNL3HoeKVuPjqN_tGHBHNbE9zE4O1PEbINPPEfCTBP_bfOuRHLEZ3usufJicTHWBxc8cTSUg7dTufmJ73chh-ngcbHm-H3E_eGSvZrRJXp7Prfs_svNz-tv1e2Pr9-vP99WppYqV51AYwz0QyNbNasWpsZIWYrN3LR9P85A0ziQGnuU7Sz6xpjOFBJaNUrqVb1lH099yyS_VkpZLzYZcg49lQG16oVUfVnaln34D3wKayz7SFrW0BVEigKJE2RiSCnSrPfRLhgPWoA--tInX7r40kdfeiiZ9-fG67jQ9C9xFlT_BQoYlRs</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>Bottoni, Ferdinando</creator><creator>Romano, Mary</creator><creator>Massacesi, Amedeo</creator><creator>Bergamini, Fulvio</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20061101</creationdate><title>Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy</title><author>Bottoni, Ferdinando ; Romano, Mary ; Massacesi, Amedeo ; Bergamini, Fulvio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-71accc0894256f650d4c221ac4f4588bf0edb9e6b8a25f184cc7c56f056b2e863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Coloring Agents</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Fluorescein Angiography</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Indocyanine Green</topic><topic>Injections</topic><topic>Macular Degeneration - complications</topic><topic>Male</topic><topic>Photochemotherapy</topic><topic>Regional Blood Flow - physiology</topic><topic>Retinal Neovascularization - drug therapy</topic><topic>Retinal Neovascularization - etiology</topic><topic>Retinal Neovascularization - physiopathology</topic><topic>Retinal Vessels - physiology</topic><topic>Triamcinolone Acetonide - therapeutic use</topic><topic>Vitreous Body</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bottoni, Ferdinando</creatorcontrib><creatorcontrib>Romano, Mary</creatorcontrib><creatorcontrib>Massacesi, Amedeo</creatorcontrib><creatorcontrib>Bergamini, Fulvio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bottoni, Ferdinando</au><au>Romano, Mary</au><au>Massacesi, Amedeo</au><au>Bergamini, Fulvio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy</atitle><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><date>2006-11-01</date><risdate>2006</risdate><volume>244</volume><issue>11</issue><spage>1528</spage><epage>1533</epage><pages>1528-1533</pages><issn>0721-832X</issn><eissn>1435-702X</eissn><abstract>The objective was to describe the remodeling of the vascular channels in stage II retinal angiomatous proliferation (RAP) treated by intravitreal injections of triamcinolone acetonide (TA) and subsequent photodynamic therapy (PDT). Stage II RAP secondary to age-related macular degeneration was documented by dynamic digital fluorescein and indocyanine green angiography in 3 consecutive patients (3 eyes). All eyes were treated with intravitreal injection of TA (4 mg, 0.1 ml) followed by PDT 5-10 days later. Indocyanine green angiography (ICGA) revealed a complete remodeling of the vascular structure of the three RAPs after treatment. The feeding retinal artery, which shunted a major part of the blood flow from the original arteriole toward the intraretinal neovascular complex before treatment, regained a normal appearance after treatment. With RAP closure, the blood flow was again directed through the original retinal arteriole, and the connection to the RAP was no longer visible. Stage II RAPs are difficult lesions to treat. A real remodeling of the vascular lesion is achieved with the combined use of intravitreal TA and PDT. This finding corroborates the need for randomized clinical trials currently under way to evaluate this combination treatment in wet, age-related macular degeneration.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>16609904</pmid><doi>10.1007/s00417-006-0311-9</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0721-832X
ispartof Graefe's archive for clinical and experimental ophthalmology, 2006-11, Vol.244 (11), p.1528-1533
issn 0721-832X
1435-702X
language eng
recordid cdi_proquest_miscellaneous_68126804
source MEDLINE; SpringerLink Journals
subjects Aged
Aged, 80 and over
Coloring Agents
Drug Therapy, Combination
Female
Fluorescein Angiography
Glucocorticoids - therapeutic use
Humans
Indocyanine Green
Injections
Macular Degeneration - complications
Male
Photochemotherapy
Regional Blood Flow - physiology
Retinal Neovascularization - drug therapy
Retinal Neovascularization - etiology
Retinal Neovascularization - physiopathology
Retinal Vessels - physiology
Triamcinolone Acetonide - therapeutic use
Vitreous Body
title Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A25%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Remodeling%20of%20the%20vascular%20channels%20in%20retinal%20angiomatous%20proliferations%20treated%20with%20intravitreal%20triamcinolone%20acetonide%20and%20photodynamic%20therapy&rft.jtitle=Graefe's%20archive%20for%20clinical%20and%20experimental%20ophthalmology&rft.au=Bottoni,%20Ferdinando&rft.date=2006-11-01&rft.volume=244&rft.issue=11&rft.spage=1528&rft.epage=1533&rft.pages=1528-1533&rft.issn=0721-832X&rft.eissn=1435-702X&rft_id=info:doi/10.1007/s00417-006-0311-9&rft_dat=%3Cproquest_cross%3E68126804%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230780421&rft_id=info:pmid/16609904&rfr_iscdi=true